Loading…
Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study
Background COVID-19 disease was first seen in December 2019 and was declared a pandemic soon after. To fight the pandemic, there is an immense need for effective vaccines. The purposes of our study were to investigate the effect of coronavirus vaccines on seizures in people with epilepsy (PWE) and a...
Saved in:
Published in: | Neurological sciences 2022-06, Vol.43 (6), p.3489-3496 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3 |
---|---|
cites | cdi_FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3 |
container_end_page | 3496 |
container_issue | 6 |
container_start_page | 3489 |
container_title | Neurological sciences |
container_volume | 43 |
creator | Özdemir, Hüseyin Nezih Dere, Birgül Gökçay, Figen Gökçay, Ahmet |
description | Background
COVID-19 disease was first seen in December 2019 and was declared a pandemic soon after. To fight the pandemic, there is an immense need for effective vaccines. The purposes of our study were to investigate the effect of coronavirus vaccines on seizures in people with epilepsy (PWE) and assess the adverse events of COVID-19 vaccine in PWE.
Methods
This was a cross-sectional study. We included epilepsy patients who got vaccinated with two or three doses at least 1 month earlier. We gathered the data using a standardized form. The form contained questions about patients’ demographic features, clinical features, and information about the vaccination and its adverse events. The questionnaire included questions about epilepsy-related adverse events.
Results
We included 178 people with epilepsy in our study. The frequency of adverse events was lower than clinical studies of the vaccines. The mean number of seizures in the month before the vaccination was 1.62, between the doses was 1.61, and after vaccination was 1.64. There was no significant difference in the number of monthly seizures before the vaccination, the month between the doses, or the month after the vaccination (
p
= 0.46).
Conclusions
The vaccines under consideration in our study were tolerated well by the epilepsy patients. The vaccines did not affect the monthly number of seizures of the PWE. A small number of patients had more seizures than normal after vaccination. We think that benefits of the vaccines outweigh the slightly increased possibility of having a seizure after vaccination. |
doi_str_mv | 10.1007/s10072-022-05956-6 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8882374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2666705635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3</originalsourceid><addsrcrecordid>eNp9UclOwzAQtRCIpfADHJAlzgFvsZMLqCqrVKkX4Go5zoSmCnGw06L-PYaU7cJhPJbmzZt58xA6puSMEqLOw8fLEsJipHkqE7mF9mmak4QLlW1v_jRTYg8dhLAghFBB-S7a4yljQhGxj6ZjD3gye7q_SmiOV8bauoWAg6kAV87jDlzXAH6r-zmGrm6gC-tLPMbWuxCSALavXWsaHPpluT5EO5VpAhxt8gg93lw_TO6S6ez2fjKeJlYo0SdU8LxUWVUIyLNUGJtnVU6jlDxVhShKAA6sZHF5WhBuGRemskyBVKW0Ego-QhcDb7csXqC00PbeNLrz9Yvxa-1Mrf9W2nqun91KZ1nGuBKR4HRD4N3rEkKvF27po46gmZRSkVTyNKLYgPoU66H6nkCJ_ri9HhzQ0QH96YCWsenk927fLV8njwA-AEIstc_gf2b_Q_sOlIeQ5g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2666705635</pqid></control><display><type>article</type><title>Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study</title><source>Springer Nature</source><creator>Özdemir, Hüseyin Nezih ; Dere, Birgül ; Gökçay, Figen ; Gökçay, Ahmet</creator><creatorcontrib>Özdemir, Hüseyin Nezih ; Dere, Birgül ; Gökçay, Figen ; Gökçay, Ahmet</creatorcontrib><description>Background
COVID-19 disease was first seen in December 2019 and was declared a pandemic soon after. To fight the pandemic, there is an immense need for effective vaccines. The purposes of our study were to investigate the effect of coronavirus vaccines on seizures in people with epilepsy (PWE) and assess the adverse events of COVID-19 vaccine in PWE.
Methods
This was a cross-sectional study. We included epilepsy patients who got vaccinated with two or three doses at least 1 month earlier. We gathered the data using a standardized form. The form contained questions about patients’ demographic features, clinical features, and information about the vaccination and its adverse events. The questionnaire included questions about epilepsy-related adverse events.
Results
We included 178 people with epilepsy in our study. The frequency of adverse events was lower than clinical studies of the vaccines. The mean number of seizures in the month before the vaccination was 1.62, between the doses was 1.61, and after vaccination was 1.64. There was no significant difference in the number of monthly seizures before the vaccination, the month between the doses, or the month after the vaccination (
p
= 0.46).
Conclusions
The vaccines under consideration in our study were tolerated well by the epilepsy patients. The vaccines did not affect the monthly number of seizures of the PWE. A small number of patients had more seizures than normal after vaccination. We think that benefits of the vaccines outweigh the slightly increased possibility of having a seizure after vaccination.</description><identifier>ISSN: 1590-1874</identifier><identifier>EISSN: 1590-3478</identifier><identifier>DOI: 10.1007/s10072-022-05956-6</identifier><identifier>PMID: 35224704</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Adverse events ; Convulsions & seizures ; Coronaviruses ; Covid-19 ; COVID-19 - prevention & control ; COVID-19 vaccines ; COVID-19 Vaccines - adverse effects ; Cross-Sectional Studies ; Epilepsy ; Humans ; Immunization ; Medicine ; Medicine & Public Health ; Neurology ; Neuroradiology ; Neurosciences ; Neurosurgery ; Pandemics ; Patients ; Psychiatry ; SARS-CoV-2 ; Seizures ; Seizures - epidemiology ; Vaccines</subject><ispartof>Neurological sciences, 2022-06, Vol.43 (6), p.3489-3496</ispartof><rights>Fondazione Società Italiana di Neurologia 2022</rights><rights>2022. Fondazione Società Italiana di Neurologia.</rights><rights>Fondazione Società Italiana di Neurologia 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3</citedby><cites>FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3</cites><orcidid>0000-0002-0651-7276</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35224704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Özdemir, Hüseyin Nezih</creatorcontrib><creatorcontrib>Dere, Birgül</creatorcontrib><creatorcontrib>Gökçay, Figen</creatorcontrib><creatorcontrib>Gökçay, Ahmet</creatorcontrib><title>Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study</title><title>Neurological sciences</title><addtitle>Neurol Sci</addtitle><addtitle>Neurol Sci</addtitle><description>Background
COVID-19 disease was first seen in December 2019 and was declared a pandemic soon after. To fight the pandemic, there is an immense need for effective vaccines. The purposes of our study were to investigate the effect of coronavirus vaccines on seizures in people with epilepsy (PWE) and assess the adverse events of COVID-19 vaccine in PWE.
Methods
This was a cross-sectional study. We included epilepsy patients who got vaccinated with two or three doses at least 1 month earlier. We gathered the data using a standardized form. The form contained questions about patients’ demographic features, clinical features, and information about the vaccination and its adverse events. The questionnaire included questions about epilepsy-related adverse events.
Results
We included 178 people with epilepsy in our study. The frequency of adverse events was lower than clinical studies of the vaccines. The mean number of seizures in the month before the vaccination was 1.62, between the doses was 1.61, and after vaccination was 1.64. There was no significant difference in the number of monthly seizures before the vaccination, the month between the doses, or the month after the vaccination (
p
= 0.46).
Conclusions
The vaccines under consideration in our study were tolerated well by the epilepsy patients. The vaccines did not affect the monthly number of seizures of the PWE. A small number of patients had more seizures than normal after vaccination. We think that benefits of the vaccines outweigh the slightly increased possibility of having a seizure after vaccination.</description><subject>Adverse events</subject><subject>Convulsions & seizures</subject><subject>Coronaviruses</subject><subject>Covid-19</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 vaccines</subject><subject>COVID-19 Vaccines - adverse effects</subject><subject>Cross-Sectional Studies</subject><subject>Epilepsy</subject><subject>Humans</subject><subject>Immunization</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neurology</subject><subject>Neuroradiology</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Psychiatry</subject><subject>SARS-CoV-2</subject><subject>Seizures</subject><subject>Seizures - epidemiology</subject><subject>Vaccines</subject><issn>1590-1874</issn><issn>1590-3478</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9UclOwzAQtRCIpfADHJAlzgFvsZMLqCqrVKkX4Go5zoSmCnGw06L-PYaU7cJhPJbmzZt58xA6puSMEqLOw8fLEsJipHkqE7mF9mmak4QLlW1v_jRTYg8dhLAghFBB-S7a4yljQhGxj6ZjD3gye7q_SmiOV8bauoWAg6kAV87jDlzXAH6r-zmGrm6gC-tLPMbWuxCSALavXWsaHPpluT5EO5VpAhxt8gg93lw_TO6S6ez2fjKeJlYo0SdU8LxUWVUIyLNUGJtnVU6jlDxVhShKAA6sZHF5WhBuGRemskyBVKW0Ego-QhcDb7csXqC00PbeNLrz9Yvxa-1Mrf9W2nqun91KZ1nGuBKR4HRD4N3rEkKvF27po46gmZRSkVTyNKLYgPoU66H6nkCJ_ri9HhzQ0QH96YCWsenk927fLV8njwA-AEIstc_gf2b_Q_sOlIeQ5g</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Özdemir, Hüseyin Nezih</creator><creator>Dere, Birgül</creator><creator>Gökçay, Figen</creator><creator>Gökçay, Ahmet</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0651-7276</orcidid></search><sort><creationdate>20220601</creationdate><title>Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study</title><author>Özdemir, Hüseyin Nezih ; Dere, Birgül ; Gökçay, Figen ; Gökçay, Ahmet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adverse events</topic><topic>Convulsions & seizures</topic><topic>Coronaviruses</topic><topic>Covid-19</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 vaccines</topic><topic>COVID-19 Vaccines - adverse effects</topic><topic>Cross-Sectional Studies</topic><topic>Epilepsy</topic><topic>Humans</topic><topic>Immunization</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neurology</topic><topic>Neuroradiology</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Psychiatry</topic><topic>SARS-CoV-2</topic><topic>Seizures</topic><topic>Seizures - epidemiology</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Özdemir, Hüseyin Nezih</creatorcontrib><creatorcontrib>Dere, Birgül</creatorcontrib><creatorcontrib>Gökçay, Figen</creatorcontrib><creatorcontrib>Gökçay, Ahmet</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Consumer Health Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Özdemir, Hüseyin Nezih</au><au>Dere, Birgül</au><au>Gökçay, Figen</au><au>Gökçay, Ahmet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study</atitle><jtitle>Neurological sciences</jtitle><stitle>Neurol Sci</stitle><addtitle>Neurol Sci</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>43</volume><issue>6</issue><spage>3489</spage><epage>3496</epage><pages>3489-3496</pages><issn>1590-1874</issn><eissn>1590-3478</eissn><abstract>Background
COVID-19 disease was first seen in December 2019 and was declared a pandemic soon after. To fight the pandemic, there is an immense need for effective vaccines. The purposes of our study were to investigate the effect of coronavirus vaccines on seizures in people with epilepsy (PWE) and assess the adverse events of COVID-19 vaccine in PWE.
Methods
This was a cross-sectional study. We included epilepsy patients who got vaccinated with two or three doses at least 1 month earlier. We gathered the data using a standardized form. The form contained questions about patients’ demographic features, clinical features, and information about the vaccination and its adverse events. The questionnaire included questions about epilepsy-related adverse events.
Results
We included 178 people with epilepsy in our study. The frequency of adverse events was lower than clinical studies of the vaccines. The mean number of seizures in the month before the vaccination was 1.62, between the doses was 1.61, and after vaccination was 1.64. There was no significant difference in the number of monthly seizures before the vaccination, the month between the doses, or the month after the vaccination (
p
= 0.46).
Conclusions
The vaccines under consideration in our study were tolerated well by the epilepsy patients. The vaccines did not affect the monthly number of seizures of the PWE. A small number of patients had more seizures than normal after vaccination. We think that benefits of the vaccines outweigh the slightly increased possibility of having a seizure after vaccination.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>35224704</pmid><doi>10.1007/s10072-022-05956-6</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-0651-7276</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1590-1874 |
ispartof | Neurological sciences, 2022-06, Vol.43 (6), p.3489-3496 |
issn | 1590-1874 1590-3478 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8882374 |
source | Springer Nature |
subjects | Adverse events Convulsions & seizures Coronaviruses Covid-19 COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - adverse effects Cross-Sectional Studies Epilepsy Humans Immunization Medicine Medicine & Public Health Neurology Neuroradiology Neurosciences Neurosurgery Pandemics Patients Psychiatry SARS-CoV-2 Seizures Seizures - epidemiology Vaccines |
title | Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T23%3A15%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20COVID-19%20vaccines%20safe%20for%20people%20with%20epilepsy?%20A%20cross-sectional%20study&rft.jtitle=Neurological%20sciences&rft.au=%C3%96zdemir,%20H%C3%BCseyin%20Nezih&rft.date=2022-06-01&rft.volume=43&rft.issue=6&rft.spage=3489&rft.epage=3496&rft.pages=3489-3496&rft.issn=1590-1874&rft.eissn=1590-3478&rft_id=info:doi/10.1007/s10072-022-05956-6&rft_dat=%3Cproquest_pubme%3E2666705635%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-1439d78fb4e9854ac98f91072957b4bdee3e2d25901b03c234afc27e67d6c6eb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2666705635&rft_id=info:pmid/35224704&rfr_iscdi=true |